Contact Us
  • Choose License Type

Global Acellular Dermal Matrices Market, by Material Type (Polyhydroxyalkanoate, Silicone, Dispersants, and Others), by Tissue Origin (Human, Porcine, Bovine, and Others), by Application (Orthopedics, Plastic Surgery, General Surgery, Repair and Replacement of Tissue, Dental, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 6,483.6 million in 2020 and is estimated to exhibit a CAGR of 15.1% during the forecast period (2020-2027).

Non-profit organizations are involved in launching new products, which are expected to drive the global market over the forecast period. For instance, in 2018, Musculoskeletal Transplant Foundation Biologics (MTF Biologics), a non-government organization, launched FlexHD Pliable PRE acellular dermal matrix that is designed especially for breast reconstruction procedures. This product may help the clinicians by reducing the time required for the procedure in the operating room.

Market players are indulged in launching new products in the market, which is expected to drive growth of the acellular dermal matrices market over the forecast period. For instance, in 2017, Integra LifeSciences Holdings Corporation launched Integra SurgiMend PRS Meshed. The Integra SurgiMend PRS Meshed acellular dermal matrices is derived from bovine dermis. The matrix is indicated for plastic surgery, reconstructive surgery, and one single stage breast reconstruction surgery post-mastectomy.

Global Acellular Dermal Matrices Market - Impact of Coronavirus (COVID – 19) Pandemic

The COVID – 19 pandemic is expected to hamper growth of the global acellular dermal matrices market during the forecast period. The coronavirus cases are increasing at a very high rate across the globe. According to World Health Organization, on 13th December, 2020, globally, 72.2 million confirmed cases of COVID-19 and 1.6 million deaths due to COVID-19 were reported.

According to the guidelines published in the American College of Surgeons: 24th March 2020, COVID 19 Pandemic Breast Cancer Consortium updated the guidelines for the management of breast cancer during the COVID-19 pandemic. The consortium did not give permission for the hospitals to carry out breast mastectomy, as the hospital resources such as ventilator and others are completely diverted for the COVID-19 management. This guideline is expected to hamper the growth of the acellular dermal matrices market growth over the forecast period.                                                            

Browse 35 Market Data Tables and 23 Figures spread through 154 Pages and in-depth TOC on, Global Acellular Dermal Matrices Market, by Material Type (Polyhydroxyalkanoate, Silicone, Dispersants, and Others), by Tissue Origin (Human, Porcine, Bovine, and Others), by Application (Orthopedics, Plastic Surgery, General Surgery, Repair and Replacement of Tissue, Dental, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa),

To know the latest trends and insights prevalent in the acellular dermal matrices market, click the link below:

https://www.coherentmarketinsights.com/market-insight/acellular-dermal-matrices-market-4362

Rising plastic surgeries among females is expected to fuel the global acellular dermal matrices market growth over the forecast period. For instance, according to the American Society of Plastic Surgeons: 2019, increasing number of females are opting for cosmetic procedures, as compared to the males. Surgeries such as breast augmentation, liposuction, eyelid surgery, rhinoplastyand tummy tuck are some of the most common surgeries performed in females.

Females

Number of procedures (2019)

Number of procedures (2018)

Number of procedures (2017)

Breast Augmentation

299,715

313,735

300,378

 

Gender

Total Procedures (2019)

% of Total Procedures

Females

14,907,175

92%

Males

1,301,675

8%

Total Procedures

16,208,850

100%

Increasing approvals for the products by the regulatory authorities is expected to drive growth of the acellular dermal matrices market over the forecast period. For instance, in 2017, Integra LifeSciences Holdings Corporation’s product, Integra SurgiMend PRS Meshed, received CE mark approval. The company initiated marketing the product in Europe in October 2017.

Key Takeaways of the Acellular Dermal Matrices Treatment:

  • The global acellular dermal matrices market is expected to exhibit a CAGR of 15.1% over the forecast period (2020-2027), owing to growth in potential markets, especially in Europe. North America accounted for major market share.
  • The increasing prevalence of fibrocystic breast disease among the women population is expected drive growth of the global acellular dermal matrices market over the forecast period. For instance, according to the National center for Biotechnology Information (NCBI), 10th July 2020, globally, fibrocystic breast disease is prevalent in women population in the age group of 30-50 years. The most common type of benign type breast disease include fibroadenomas and it constitutes around 70-95% of the fibrocystic breast disease, and the disease is more prevalent in the age group of 17 -20 years.
  • Some of the major players operating in the global acellular dermal matrices market include Zimmer Biomet, Stryker Corporation, Staumann, Allergan, Inc., Conmed, Integra LifeSciences Corporation, Aziyo Biologics, Hospital Innovations, Medtronic, Inc., Synthes, Inc., Gunze Corp., Cook Medical Incorporated, C. R. Bard, Inc., and HANS BIOMED CORP.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner